Glucose tolerance test is a diagnostic mechanism to measure body’s response to changes in sugar levels, thus, it can be used to diagnose diabetes. The test is known as oral glucose tolerance test (OGTT). The procedure involves a normal blood test as part of pilot study. Post this, the patient is asked to drink a liquid containing glucose. Subsequently, the blood test is carried out again to contemplate changes is blood glucose level. Higher glucose level signals non-absorption of sugar by body cells. Glucose challenge test is the short version of glucose tolerance test. It involves drinking concentrated glucose solution and subsequent blood test to contemplate blood sugar levels.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
At the early phase of the COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global markets. These players achieved an edge over other diagnostics players capitalizing on the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
Owing to such factors, COVID 19 is expected to have a significant impact on the global glucose tolerance test market.
Top Impacting Factors
- Increasing prevalence of incidents pertaining to type 2 diabetes is anticipated to drive market growth for global glucose tolerance test market. This is attributed to rising geriatric population in regions such as Japan, Europe, and Vietnam coupled with rising awareness of advanced diagnostic tests and therapeutic mechanisms.
- Technological innovations with respect to healthcare industry are anticipated to drive market growth further. These include incorporation of innovations such as deep learning and robotics in diagnostic industry.
- Rise in government funding allotted to research and development of diabetic therapeutics and diagnostic industry is further expected to drive market growth. The trend is primarily being witnessed in emerging economies such as India, China, and Brazil.
- Rising awareness on diabetes mellitus in high population regions of the world coupled with robust investment influx for design and development of diagnosing the disease at large scale is anticipated to further drive market growth.
- However, high costs associated with design and development of diagnostic test pertaining to diabetes mellitus may hamper market growth. The restraint is anticipated to be witnessed more in underdeveloped regions such as Africa and South America.
- Additionally, stringent reimbursement policies and insurance policies in emerging economies may further restraint market penetration into deeper geographical trenches of high population countries.
Key Market Trends
- North America is anticipated to witness dominance in glucose tolerance test market pertaining to rising incidents of diabetes mellitus coupled with growing awareness of advanced diagnostic mechanisms.
- A recent study conducted at University of Colorado has confirmed that a short-term 1hour oral glucose tolerance test (OGTT) is as efficient as potent as a 2hour (OGTT).
Key Benefits of the Report
- This study presents the analytical depiction of the global glucose tolerance test industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global glucose tolerance test market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Global Glucose Tolerance Test Report
- Which are the leading players active in the global glucose tolerance test market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the global glucose tolerance test market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What are the impacts of COVID-19 in the industry?
- What is global glucose tolerance test?
- What is the global glucose tolerance test market prediction in the future?
- What are the current trends and predicted trends?
Glucose Tolerance Test Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Disease Indication |
|
 By End User |
|
 By Region |
|
 Key Market Players | Bayer AG, Merck KGaA, Panasonic, Thermo Fisher Scientific Inc., Trividia Health Inc., Dexcom, Inc., Cleveland Heartlab Inc, F.Hoffman-La Roche Ltd., Penlan Healthcare Ltd., Johnson and Johnson Inc, Ascensia Diabetes Care Holdings AG, Medtronic Inc, Laboratory Corporation of American Holdings, ARUP Labs, Abbott Labs, E-Zlab Health Services, Sanofi, Lifescan IP Holdings, Quest Diagnostics Incorporated |
Loading Table Of Content...
